Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 21.
doi: 10.1007/s00210-025-04079-x. Online ahead of print.

Geniposide protects against cerebral ischemic injury by targeting SOX2/RIPK1 axis

Xiaogang He  1 , Yi Zhang  1 , Chunyang Xu  1 , Rong Zhang  2 , Ya Li  3
Affiliations

Geniposide protects against cerebral ischemic injury by targeting SOX2/RIPK1 axis

Xiaogang He et al. Naunyn Schmiedebergs Arch Pharmacol. .

Abstract

Convincing evidence has indicated that geniposide possesses neuroprotective effects in ischemic stroke. This study is designed to explore the potential molecular mechanism of geniposide in oxygen-glucose deprivation/reoxygenation (OGD/R)-treated BV-2 microglial cells and middle cerebral artery occlusion (MCAO) mice. OGD/R model in BV2 microglial cells was established in this research. Cell viability and apoptosis were determined using Cell Counting Kit-8 (CCK-8) and flow cytometry assays. Protein levels of B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax), microtubule-associated protein light chain 3 (LC3)-II/LC3-I, Beclin-1, inducible nitric oxide synthase (iNOS), CD86, sex determining region Y-box 2 (SOX2), receptor-interacting serine/threonine-protein kinase 1 (RIPK1), TNF-α, IL-1β, ARG1, and CD163 were detected by western blot assay. RIPK1 mRNA level was determined using real-time quantitative polymerase chain reaction (RT-qPCR). TNF-α and IL-1β levels were analyzed using ELISA kits. After JASPAR analysis, binding between SOX2 and RIPK1 promoter was predicted and verified using chromatin immunoprecipitation (ChIP) and dual-luciferase reporter assays. The effects of geniposide on cerebral ischemic injury were assessed using MCAO mice in vivo. Geniposide treatment relieved OGD/R-triggered BV-2 cell viability promotion and apoptosis, autophagy, inflammatory response, and M1 polarization inhibition in vitro. SOX2 and RIPK1 expression was decreased in OGD/R-treated BV-2 cells. In mechanism, SOX2 upregulated RIPK1 transcription by binding to the RIPK1 promoter region. Geniposide administration significantly alleviated cerebral ischemic injury in MCAO mice in vivo. Geniposide administration protects against cerebral ischemic injury through regulating the SOX2/RIPK1 axis, providing a potential direction for the application of geniposide in the treatment of ischemic stroke.

Keywords: Geniposide; Inflammatory response; OGD/R; RIPK1; SOX2.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: All processes involving this animal experiment were approved by the Animal Ethics Committee of Kunshan Hospital of Chinese Medicine. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Similar articles

See all similar articles

References

    1. Abdelhady R, Younis NS, Ali O, Shehata S, Sayed RH, Nadeem RI (2023) Cognitive enhancing effects of pazopanib in D-galactose/ovariectomized Alzheimer’s rat model: insights into the role of RIPK1/RIPK3/MLKL necroptosis signaling pathway. Inflammopharmacology 31(5):2719–2729. https://doi.org/10.1007/s10787-023-01269-y - DOI - PubMed - PMC
    1. Chen L, Li M, Yang Z, Tao W, Wang P, Tian X et al (2020) Gardenia jasminoides Ellis: ethnopharmacology, phytochemistry, and pharmacological and industrial applications of an important traditional Chinese medicine. J Ethnopharmacol 257:112829. https://doi.org/10.1016/j.jep.2020.112829 - DOI - PubMed
    1. Chen Z, Fan T, Zhao X, Zhang Z (2021) Depleting SOX2 improves ischemic stroke via lncRNA PVT1/microRNA-24-3p/STAT3 axis. Mol Med 27(1):107. https://doi.org/10.1186/s10020-021-00346-8 - DOI - PubMed - PMC
    1. Deng XX, Li SS, Sun FY (2019) Necrostatin-1 prevents necroptosis in brains after ischemic stroke via inhibition of RIPK1-mediated RIPK3/MLKL signaling. Aging Dis 10(4):807–817. https://doi.org/10.14336/ad.2018.0728 - DOI - PubMed - PMC
    1. Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W et al (2022) World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke 17(1):18–29. https://doi.org/10.1177/17474930211065917 - DOI - PubMed

LinkOut - more resources